Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus or SLE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06916806
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesRheumatoid Arthritis
AstraZeneca 72
Early research (Phase 1)Study completedNCT06013995
What this trial is testing

Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

Who this might be right for
Lupus
Bristol-Myers Squibb 45
Large-scale testing (Phase 3)WithdrawnNCT00382837
What this trial is testing

Study of Epratuzumab in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
UCB Pharma
Testing effectiveness (Phase 2)Study completedNCT01031836
What this trial is testing

Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 30
Testing effectiveness (Phase 2)Study completedNCT01393132
What this trial is testing

Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye

Who this might be right for
Dry EyeSjogren's SyndromeGraft vs. Host Disease
Michigan Cornea Consultants, PC 9
Large-scale testing (Phase 3)Ended earlyNCT00626197
What this trial is testing

Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Genentech, Inc. 381
Early research (Phase 1)Study completedNCT03334851
What this trial is testing

Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis

Who this might be right for
Systemic Lupus ErythematosusRheumatoid Arthritis
Pfizer 74
Early research (Phase 1)Active Not RecruitingNCT06265220
What this trial is testing

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IVRefractory Systemic Lupus Erythematosus+1 more
Artiva Biotherapeutics, Inc. 51
Not applicableStudy completedNCT04481633
What this trial is testing

Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection

Who this might be right for
COVID-19
University Hospital, Toulouse 547
Early research (Phase 1)Study completedNCT02151409
What this trial is testing

Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects

Who this might be right for
InflammationSystemic Lupus ErythematosusRheumatoid Arthritis+1 more
Novo Nordisk A/S 60
Not applicableStudy completedNCT00010400
What this trial is testing

Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome

Who this might be right for
Systemic Lupus ErythematosusAntiphospholipid Antibody Syndrome
Johns Hopkins University 35
Testing effectiveness (Phase 2)Study completedNCT00556192
What this trial is testing

Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Chinese University of Hong Kong 20
Not applicableAvailableNCT04159597
What this trial is testing

Expanded Access to Upadacitinib

Who this might be right for
Crohn DiseaseUlcerative ColitisIdiopathic Arthritis (Including sJIA, pJIA, or JPsA)+11 more
AbbVie
Large-scale testing (Phase 3)Ended earlyNCT02514967
What this trial is testing

CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals 3
Testing effectiveness (Phase 2)Ended earlyNCT05879718
What this trial is testing

Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus, Cutaneous
Pfizer 8
Testing effectiveness (Phase 2)Ended earlyNCT05781750
What this trial is testing

Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

Who this might be right for
Lupus Nephritis
Kezar Life Sciences, Inc. 84
Early research (Phase 1)UnknownNCT06316076
What this trial is testing

Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisIdiopathic Inflammatory Myopathies+1 more
RenJi Hospital 48
Early research (Phase 1)Study completedNCT02306629
What this trial is testing

Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood

Who this might be right for
Systemic Lupus Erythematosus
UCB Biopharma S.P.R.L. 42
Large-scale testing (Phase 3)Looking for participantsNCT07332481
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc. 202
Early research (Phase 1)Looking for participantsNCT06822881
What this trial is testing

CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)
Beijing GoBroad Hospital 27
Next Page